Mark J. Sorbero
-
The Association of State Policies and Opioid Analgesic Amount Dispensed from Retail Pharmacies
2025
-
Associations Between State Policies Facilitating Telehealth and Buprenorphine Episode Initiation and Duration Early in the COVID Pandemic
2024
-
A Longitudinal Multivariable Analysis: State Policies and Opioid Dispensing in Medicare Beneficiaries Undergoing Surgery
2024
-
Use of Inpatient Psychiatric Facilities by Medicare Beneficiaries with Dementia
2024
-
Buprenorphine Treatment Episodes During the First Year of COVID: A Retrospective Examination of Treatment Initiation and Retention
2023
-
Differences in Medicaid Expansion Effects on Buprenorphine Treatment Utilization by County Rurality and Income: A Pharmacy Data Claims Analysis from 2009-2018
2023
-
State Policy and the Breadth of Buprenorphine-Prescriber Networks in Medicaid Managed Care
2023
-
Buprenorphine Treatment Episode Duration, Dosage, and Concurrent Prescribing of Benzodiazepines and Opioid Analgesics: The Effects of Medicaid Prior Authorization Policies
2022
-
Differences in Buprenorphine Treatment Quality Across Physician Provider Specialties
2022
-
The Effect of State Policies on Rates of High-Risk Prescribing of an Initial Opioid Analgesic
2022
-
Sociodemographic Differences in Quality of Treatment to Medicaid Enrollees Receiving Buprenorphine
2022
-
State Policies and Buprenorphine Prescribing by Nurse Practitioners and Physician Assistants
2022
-
Subsequent Buprenorphine Treatment Following Emergency Physician Buprenorphine Prescription Fills: A National Assessment 2019 to 2020
2022
-
Concentration of Patient Care Among Buprenorphine-Prescribing Clinicians in the U.S.
2021
-
Does Integration of Palliative Care and Infection Management Reduce Hospital Transfers Among Nursing Home Residents?
2021
-
Individual and Community Factors Associated with Naloxone Co-prescribing Among Long-term Opioid Patients: A Retrospective Analysis
2021
-
Infection Trends in Home Health Care, 2013-2018
2021
-
Patient, Prescriber, and Community Factors Associated with Filled Naloxone Prescriptions Among Patients Receiving Buprenorphine 2017–18
2021
-
Rapid Discontinuation of Chronic, High-Dose Opioid Treatment for Pain: Prevalence and Associated Factors
2021
-
Trends in Visits to Substance Use Disorder Treatment Facilities in 2020
2021
-
Growth and Distribution of Buprenorphine-Waivered Providers in the United States, 2007–2017
2020
-
Impact of a Medicaid Policy on Preventive Oral Health Services for Children with Intellectual Disabilities, Developmental Disabilities, or Both
2020
-
Delivery of Preventive Oral Health Services by Rurality: A Cross-Sectional Analysis
2019
-
Primary and Behavioral Health Care Integration Program: Impacts on Health Care Utilization, Cost, and Quality
2019
-
Association Between Type of Health Insurance and Children's Oral Health, NHANES 2011–2014
2018
-
High-Risk Prescribing to Medicaid Enrollees Receiving Opioid Analgesics: Individual- and County-Level Factors
2018
-
Impact of Medicaid Policy on the Oral Health of Publicly Insured Children
2018
-
A Population-Based Examination of Trends and Disparities in Medication Treatment for Opioid Use Disorders Among Medicaid Enrollees
2018
-
Infection Trends in US Nursing Homes, 2006–2013
2017
-
Simulated Effects of Policies to Reduce Diabetes Risk Among Adults With Schizophrenia Receiving Antipsychotics
2017
-
Opioid Analgesic and Benzodiazepine Prescribing Among Medicaid-enrollees with Opioid Use Disorders: The Influence of Provider Communities
2016
-
Physician Capacity to Treat Opioid Use Disorder with Buprenorphine-Assisted Treatment
2016
-
Growth in Buprenorphine Waivers for Physicians Increased Potential Access to Opioid Agonist Treatment, 2002-11
2015
-
Implementing a Web-Based Intervention to Train Community Clinicians in an Evidence-Based Psychotherapy: A Pilot Study
2015
-
Policies to Support a Better Treatment for Heroin and Prescription Opioid Abuse: Unlike Methadone, Buprenorphine Can Be Taken at Home, but Greater Access is Key
2015
-
Psychosocial Treatment of Bipolar Disorder: Clinician Knowledge, Common Approaches, and Barriers to Effective Treatment
2015
-
Supply of Buprenorphine Waivered Physicians: The Influence of State Policies
2015
-
Where Is Buprenorphine Dispensed to Treat Opioid Use Disorders? The Role of Private Offices, Opioid Treatment Programs, and Substance Abuse Treatment Facilities in Urban and Rural Counties
2015
-
Determining Engagement in Services for High-Need Individuals with Serious Mental Illness
2014
-
Psychometric Investigation of a Brief Measure of Outcomes in Children's Mental Health
2014
-
Reengagement of High-Need Individuals with Serious Mental Illness After Discontinuation of Services
2014
-
Using Claims Data to Generate Clinical Flags Predicting Short-Term Risk of Continued Psychiatric Hospitalizations
2014
-
Predictors of Adequate Depression Treatment Among Medicaid-enrolled Youth
2013
-
Use of a Computerized Medication Shared Decision Making Tool in Community Mental Health Settings: Impact on Psychotropic Medication Adherence
2013
-
Concurrent Mental Health Therapy Among Medicaid-enrolled Youth Starting Antipsychotic Medications
2012
-
Impact of a Private Health Insurance Mandate on Public Sector Autism Service Use in Pennsylvania
2012
-
The Impact of Buprenorphine on Treatment of Opioid Dependence in a Medicaid Population: Recent Service Utilization Trends in the Use of Buprenorphine and Methadone
2012
-
Predictors of Adequate Depression Treatment Among Medicaid-enrolled Adults
2010
-
Use of Outcomes Information in Child Mental Health Treatment: Results from a Pilot Study
2010
-
Substance Abuse Detoxification and Residential Treatment Among Medicaid-enrolled Adults: Rates and Duration of Subsequent Treatment
2009
-
Predictors of Timely Follow-Up Care Among Medicaid-Enrolled Adults After Psychiatric Hospitalization
2007
